August 2026– date –
-
Lumos Diagnostics Partners with Alpha Medical for Exclusive Romanian Distribution of FebriDx Rapid Respiratory Infection Test, Boosting European Expansion
MarketScreener Australia Overview Lumos Diagnostics Holdings has announced an exclusive distribution agreement with Romania's Alpha Medical for the commercialization of its FebriDx rapid respiratory infection POCT diagnostic test across ... -
Cambridge Researchers Integrate Functional Electronics on Biodegradable Textile Substrates, Paving Way for Sustainable Wearables
Cambridge Centre for Circular Economy UK Overview Researchers at the University of Cambridge have demonstrated the capability to embed functional electronic components directly onto textile substrates, marking a significant advance in bi... -
FDA Clears Dexcom’s Stelo Glucose Biosensor System as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children Ages 2+
Weence.com USA Overview On June 12, 2026, the FDA approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged 2 and older who do not use insulin. This system, wh... -
Novel Graphene-Hydrogel Electrodes Stretch to 8000%, Enable Stable Biosignal Monitoring Through Sweat and Motion
Graphene Info Unknown Overview Researchers have developed innovative graphene-hydrogel electrodes that maintain robust skin contact and stable biosignal monitoring even with sweat, hair, and strenuous motion. This hydrogel exhibits an ex... -
FLOWBIO App Integrates Lab-Grade Sweat Sensor to Optimize Athlete Hydration Strategies
App Store Unknown Overview The FLOWBIO app, paired with the world's most accurate sweat sensor, links sweat data directly to an athlete's performance, recovery, and progress. The FLOWBIO sensor delivers lab-grade accurate, real-time meas... -
Cizzle Biotechnology Launches CIZ1B Blood Test for Early Lung Cancer Detection in US Market
The York Press UK Overview UK-based Cizzle Biotechnology Holdings has commenced the commercial rollout of its CIZ1B biomarker blood test for early lung cancer detection in the United States. The initial launch in Dallas-Fort Worth and Sa... -
Siemens Healthineers Unveils Industry-Leading Menu for Core Lab Capillary Testing, Enhancing Diagnostic Capabilities
Science Branding Communications, Inc. Germany Overview Siemens Healthineers launched a new, industry-leading menu for core lab capillary testing on July 28, 2026. This announcement signifies a major advancement in diagnostic capabilities... -
Freenome Secures FDA Approval for Blood-Based Colorectal Cancer Test, Advancing Non-Invasive Diagnostics
MedTech Dive USA Overview Freenome has received FDA approval for its blood-based test for colorectal cancer, marking a significant regulatory milestone in non-invasive cancer diagnostics. This development is a major advance in the field ... -
Will FDA’s Commitment to AI in Healthcare Waver? MedTech Dive Discusses Regulatory Trajectory for Biosensors and Diagnostics
MedTech Dive USA Overview A MedTech Dive article examines whether the U.S. FDA's commitment to artificial intelligence in healthcare, particularly for biosensors and diagnostics, will shift. This discussion reflects ongoing industry deba... -
CoolLED Spotlights Advanced Multi-Color Imaging Biosensors Enabling Single-Molecule Detection with High Throughput and Sensitivity
CoolLED UK Overview CoolLED highlighted an article discussing a novel biosensor concept that achieves single-molecule imaging with high throughput and sensitivity using a multi-color imaging setup. This advanced biosensor technology sign...
